Researchers

no image

MURATA Daiki
Assistant Professor A in Medical School
Faculty Department of Medicine
Researchmap https://researchmap.jp/muratad221217

Education and Career

Education

  • 2013/04 - 2019/03 , Saga University, School of Medicine,
  • 2025/04 - Today , Kindai University, Graduate School of Medical Sciences,

Academic & Professional Experience

  • Apr. 2025 - Today , Kindai University Faculty of Medicine, Department of Medical Oncology
  • Apr. 2024 - Mar. 2025 , Kurume University School of Medicine Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine
  • Oct. 2022 - Mar. 2024 , Saga-Ken Medical Centre Koseikan Division of Respiratory Medicine
  • Apr. 2021 - Sep. 2022 , Kurume University School of Medicine Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine
  • Apr. 2019 - Mar. 2021 , National Hospital Organization, Kure Medical Center and Chugoku Cancer Center junior resident

Research Activities

Research Interests

免疫療法, 肺癌

Published Papers

  1. Biomarker analyses to predict benefit of immune checkpoint inhibitors for EGFR-mutated non-small cell lung cancer.
    Azuma K; Osuga M; Itoh S; Kawa Y; Kozuki T; Toi Y; Murotani K; Izumi M; Murata D; Hata A; Sugawara S; Satouchi M; Yamamoto N; Koh Y
    Cancer treatment and research communications  3, Feb. 2026 
  2. Soluble Immune Mediators Regulated by CD163+ Macrophages or CD8+ TILs According to EGFR Mutation Status During Anti-PD-1/L1 Monotherapy for NSCLC
    Daiki Murata; Koichi Azuma; Kenta Murotani; Akihiko Kawahara; Tomoaki Hoshino
    2026 
  3. Biomarker study on pneumonitis in durvalumab maintenance therapy after chemoradiotherapy for stage III non-small cell lung cancer
    Ryo Yano; Takaaki Tokito; Kenta Murotani; Daiki Murata; Shingo Tsuneyoshi; Hidenobu Ishii; Koichi Azuma; Tomoaki Hoshino
    BMC Cancer  19, Dec. 2025  , Refereed

MORE

Books etc

  1. - , Daiki Murata; Hidetoshi Hayashi , ドライバー遺伝子変異・転座陽性例の薬物療法─ROS1融合遺伝子，BRAF遺伝子V600E変異，MET遺伝子変異，RET融合遺伝子，NTRK融合遺伝子，KRAS遺伝子G12C変異，HER2遺伝子変異 , 医歯薬出版株式会社 , May. 2026
  2. - , Daiki Murata; Koichi Azuma , KRAS G12C変異陽性非小細胞肺癌に対する薬物療法 , 科学評論社 , Jul. 2025
  3. The cutting edge of immune checkpoint therapy , Daiki Murata; Koichi Azuma , 肺がん領域における最近のトピックス , 株式会社 北隆館 / 株式会社 ニュー・サイエンス社 , Apr. 2025

MORE

Conference Activities & Talks

  1. - , Daiki Murata , - , 11, Apr. 2026

MISC

  1. Efficacy of Chemotherapy with or without Immunotherapy in Elderly NSCLC Patients with Low PD-L1 Expression , 谷口寛和; 河内勇人; 畑妙; 山田忠明; 後藤康洋; 天野明彦; 木島貴志; 渡部聡; 古屋直樹; 大場智広; 生駒龍興; 中尾明; 谷村恵子; 吉村彰紘; 福井朋也; 村田大樹; 解良恭一; 高山浩一 , 日本呼吸器学会誌(Web) , 14 , 2025
  2. 悪液質を有する非小細胞肺癌患者において活性型および非活性型Ghrelinが免疫チェックポイント阻害剤単剤治療に及ぼす影響に関する検討 , 村田 大樹; 東 公一; 西井 裕哉; 時任 高章; 星野 友昭 , 肺癌 , 64 , 3 , 213 , 214 , Jun. 2024
  3. 腫瘍 免疫療法・予後予測因子 Multiplex assayを用いた非小細胞肺癌に対する免疫チェックポイント阻害剤単剤治療における予後予測因子の探索的検討 , 村田 大樹; 東 公一; 西井 裕哉; 時任 高章; 星野 友昭 , 日本呼吸器学会誌 , 13 , 増刊 , 194 , 194 , Mar. 2024

MORE

Awards & Honors

  1. Apr. 2026, The Japanese Society of Internal Medicine, Encouragement Award of The Japanese Society of Internal Medicine
  2. Mar. 2024, WILEY, WILEY Top Downloaded Article（Thoracic Cancer）
  3. Jan. 2024, 日本内科学会, 第344回日本内科学会九州地方会 指導医賞

MORE